◆英語タイトル:Hemarina SA - Product Pipeline Analysis, 2017 Update
◆商品コード:DATA8010079
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月27日
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Hemarina SA (Hemarina) is a biotechnology company, which focuses on the research and development of marine oxygen carriers for therapeutic and industrial uses. The company develops hemoglobin-based oxygen carriers (HBOCs) for organ preservation. Due to the absence of vasoconstrictor effect, Hemarina’s HBOCs do not cause side effects, particularly high blood pressure. Its product portfolio includes an additive for organ preservation solution, oxygenating dressing for hypoxic and chronic wounds, oxygen carriers, and a cell growth activator for cell culture and recombinant protein production for research and development laboratories. The company has operational presence in the US and Noirmoutier Island. Hemarina is headquartered in Morlaix, Bretagne, France.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Hemarina SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Hemarina SA Company Overview 4
Hemarina SA Company Snapshot 4
Hemarina SA Pipeline Products and Ongoing Clinical Trials Overview 4
Hemarina SA – Pipeline Analysis Overview 7
Hemarina SA – Key Facts 7
Hemarina SA – Major Products and Services 8
Hemarina SA Pipeline Products by Development Stage 9
Hemarina SA Ongoing Clinical Trials by Trial Status 11
Hemarina SA Pipeline Products Overview 13
HEMHealing 13
HEMHealing Product Overview 13
HEMO2life 14
HEMO2life Product Overview 14
HEMO2life Clinical Trial 15
HEMOXYCarrier 16
HEMOXYCarrier Product Overview 16
Hemarina SA – Key Competitors 17
Hemarina SA – Key Employees 18
Hemarina SA – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Hemarina SA, Recent Developments 20
Nov 14, 2017: Brest University Hospital and HEMARINA announce positive Top-line results from first clinical trial of HEMO2life in kidney preservation before human transplantation. 20
Jul 26, 2016: Kidney transplant: OxyOp multicenter clinical trial evaluating the use of the oxygen carrier HEMO2life will continue in accordance with the protocol established 20
Feb 09, 2016: Business France Announces Creative Next U.S. Contest Winner 21
Feb 11, 2014: HEMARINA, ORPHY, the UBO laboratory, and the University Hospital of Brest launch HEMOXYCHOC, the preclinic project designed to assess the efficacy & safety of HEMOXYCarrier in the management of uncontrolled hemorrhagic shock 22
Sep 26, 2013: HEMARINA & LFB Biomanufacturing announced the signature of an agreement for the manufacturing of HEMO2life 22
Apr 30, 2013: HEMARINA expands its operations to Boston U.S.A. Hemarina will be the company affiliate for the America 23
Nov 07, 2011: ANR selects Hemarina’s HEMO2Perf project 23
Aug 31, 2011: Hemarina Announces Publication of HEMO2Life in American Journal of Transplantation 24
Feb 28, 2011: HEMARINA Signs Research Agreement to Study 24
Appendix 26
Methodology 26
About GlobalData 28
Contact Us 28
Disclaimer 29
List of Tables
Hemarina SA Pipeline Products and Ongoing Clinical Trials Overview 4
Hemarina SA Pipeline Products by Equipment Type 5
Hemarina SA Pipeline Products by Indication 6
Hemarina SA Ongoing Clinical Trials by Trial Status 6
Hemarina SA, Key Facts 7
Hemarina SA, Major Products and Services 8
Hemarina SA Number of Pipeline Products by Development Stage 9
Hemarina SA Pipeline Products Summary by Development Stage 10
Hemarina SA Ongoing Clinical Trials by Trial Status 11
Hemarina SA Ongoing Clinical Trials Summary 12
HEMHealing - Product Status 13
HEMHealing - Product Description 13
HEMO2life - Product Status 14
HEMO2life - Product Description 14
HEMO2life - Evaluation of a Marine OXYgen Carrier: HEMO2Life for hypOthermic Kidney Graft Preservation, Before Transplantation 15
HEMOXYCarrier - Product Status 16
HEMOXYCarrier - Product Description 16
Hemarina SA, Key Employees 18
Hemarina SA, Subsidiaries 19
Glossary 27